- Home
- SLVM vs NEO Comparison
SLVM vs NEO Comparison
Compare SLVM & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLVM | NEO |
|---|---|---|
| Founded | 1898 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Paper | Precision Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | SLVM | NEO |
|---|---|---|
| Price | $49.78 | $12.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $54.00 | $11.38 |
| AVG Volume (30 Days) | 263.3K | ★ 2.0M |
| Earning Date | 02-12-2026 | 02-17-2026 |
| Dividend Yield | ★ 3.57% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.36 | N/A |
| Revenue | ★ $3,431,000,000.00 | $709,162,000.00 |
| Revenue This Year | N/A | $10.86 |
| Revenue Next Year | N/A | $9.70 |
| P/E Ratio | $11.56 | ★ N/A |
| Revenue Growth | N/A | ★ 10.10 |
| 52 Week Low | $37.52 | $4.72 |
| 52 Week High | $82.04 | $15.32 |
Technical Indicators
Market Signals| Indicator | SLVM | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 49.06 | 47.20 |
| Support Level | $49.04 | $12.04 |
| Resistance Level | $51.56 | $13.29 |
| Average True Range (ATR) | 1.66 | 0.64 |
| MACD | -0.16 | -0.10 |
| Stochastic Oscillator | 45.59 | 17.68 |
Price Performance
Historical ComparisonAbout SLVM Sylvamo Corporation
Sylvamo Corp is an uncoated papers company with a broad portfolio of top-tier brands and low-cost, large-scale paper mills, it produces uncoated freesheet (UFS) for paper products such as cut size and offset paper, as well as market pulp. The company offers Copy and Printer papers, Commercial Printing papers, Converting papers and Specialty papers. It operates in three geographical segments: Europe, Latin America, and North America. Key revenue is generated from North America.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.